Vanguard Portfolio Management
TARA icon

Vanguard Portfolio Management’s Protara Therapeutics TARA Stock Holding History

Vanguard Portfolio Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Buy
491,657
+79,053
+19% +$376K ﹤0.01% 2755
2026
Q1 		$2.15M Buy
+412,604
New +$2.44M ﹤0.01% 2577

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Vanguard Portfolio Management's TARA Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Protara Therapeutics (TARA) stake by 19% in Q2 2026, buying an estimated $376K and bringing the position to 491,657 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2755.

Vanguard Portfolio Management first reported a position in TARA in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.15M in Q1 2026. 118 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Vanguard Portfolio Management held 491,657 shares of Protara Therapeutics worth $1.88M as of Q2 2026.
  • Vanguard Portfolio Management bought 79,053 Protara Therapeutics shares in Q2 2026, an estimated $376K.
  • Protara Therapeutics made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2755 holding.
  • Vanguard Portfolio Management first reported a position in Protara Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Protara Therapeutics position peaked at $2.15M in Q1 2026.
  • 118 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.